Search results
Nvidia Recently Bought 5 Artificial Intelligence (AI) Stocks, and 1 Is Absolutely Soaring
The Motley Fool via AOL· 5 hours agoOn a positive note, management believes it could generate a profit during 2025 on the basis of...
The Biden Administration Plans to Reschedule Marijuana: 3 Things You Need to Know Before Rushing to...
Motley Fool via Yahoo Finance· 4 days agoBut if full-on legalization isn't inevitable, then these stocks won't see any direct benefit from...
Opinion: The real reason why Oregon recriminalizing drugs is a cautionary tale
Los Angeles Times Opinion via Yahoo News· 2 days agoRising homelessness and visible crime in Portland fed panic over a drug decriminalization measure...
Zacks Industry Outlook Highlights Mettler-Toledo and Bruker
Zacks via Yahoo Finance· 4 hours agoInherent in any investment is the potential for loss. This material is being provided for...
Hygrovest increases Net Asset Value per share by 23% to A$0.1355 in April
Proactive Investors· 7 days agoThis was primarily due to a 50% increase in the Enterprise Value to Net Revenue Multiple (EV/NRM)...
Arguments to keep marijuana illegal don’t hold up against reality in Florida | Opinion
Miami Herald via Yahoo News· 17 hours agoThe report analyzes “marijuana use disorder” data and doesn’t claim one in three become addicted....
Week in Insights: Mansion Tax Debates Won’t End Any Time Soon
Bloomberg Law· 3 days agoSuch levies aim to ameliorate market inequities and help pay for affordable housing construction. In Los Angeles, Measure ULA, created by a ballot measure in 2022, was projected to raise $900 ...
Weed it and Reap: Cannabis Rescheduling’s Impact on Tax Deductions | JD Supra
JD Supra· 6 days agoInternal Revenue Code Section 280E prevents cannabis operators from taking ordinary business expense deductions because cannabis is currently classified as a Schedule I < ...
Merck KGaA's Q1 adjusted profit declines less than feared
Reuters via Yahoo News· 9 hours agoThat beat the average analyst estimate of 1.36 billion euros posted on the company's website, helped...
BioMarin cutting about 170 jobs after shuffling drug portfolio - San Francisco Business Times
The Business Journals· 14 hours agoRare-disease drug maker BioMarin Pharmaceutical Inc., whose new CEO last month outlined the shelving...